Nevada 2023 Regular Session

Nevada Senate Bill SB390

Introduced
3/27/23  
Refer
3/27/23  
Report Pass
4/24/23  
Refer
4/24/23  
Report Pass
5/29/23  
Engrossed
5/30/23  
Refer
5/30/23  
Report Pass
6/2/23  
Enrolled
6/8/23  
Chaptered
6/13/23  

Caption

Enacts provisions relating to neurodegenerative diseases. (BDR 40-135)

Budget

To implement the provisions of SB390, the bill appropriates $150,000 from the State General Fund. This funding will support the establishment and maintenance of the reporting system, as well as the operation of an associated website for transparency and dissemination of information. The budget allocations are intended to ensure that the Department of Brain Health has the necessary resources to fulfill its new responsibilities under the law, contributing to the effective monitoring and management of neurodegenerative diseases throughout Nevada.

Impact

SB390 amends existing state laws to facilitate the integration of a comprehensive reporting system concerning neurodegenerative diseases, thereby enhancing the availability of health data for research and public health interventions. By requiring the reporting of specific disease-related information, the bill significantly contributes to institutional knowledge and allows for better resource allocation, policy development, and targeted health care services. Furthermore, it obligates health care providers to maintain patient confidentiality while sharing necessary data with the designated department, ensuring ethical standards are upheld in the management of sensitive health information.

Summary

Senate Bill No. 390 establishes a framework for the reporting and analysis of information on neurodegenerative diseases, including conditions like Parkinson's disease, Alzheimer's disease, and multiple sclerosis. This initiative aims to improve the understanding and management of these diseases by creating a formal reporting system that engages health care providers and patients across the state. Specifically, the bill designates the Department of Brain Health at the University of Nevada, Las Vegas as responsible for the implementation and maintenance of this system, promoting a centralized approach to data collection.

Contention

While there is broad support for efforts to improve research and understanding of neurodegenerative diseases, some concerns have been raised regarding privacy and data security. Critics emphasize the importance of safeguarding patients' rights and the potential risks of data misuse. The bill seeks to address these concerns through provisions that emphasize patient consent for data sharing and stringent confidentiality protocols. However, there may still be debate over the adequacy of these protections and the balance between necessary data transparency and individual privacy.

Companion Bills

No companion bills found.

Previously Filed As

NV SB1525

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

NV SB1047

An act to amend Sections 103871 and 103871.2 of the Health and Safety Code, relating to public health.

NV HB704

Establishing the Neurodegenerative Disease Research Program and the Neurodegenerative Disease Research Program Fund; and imposing duties on the Department of Health.

NV SB1812

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

NV SB348

Makes revisions relating to laboratory testing. (BDR 40-123)

NV AB360

Revises provisions relating to testing for sexually transmitted diseases. (BDR 40-745)

NV S4213

Requires DOH to develop and maintain centralized neurodegenerative disorders database.

NV HB2456

Modifies provisions relating to infectious or communicable diseases

NV SB828

Enacts provisions relating to medical testing

NV SB7

Revises provisions relating to occupational diseases. (BDR 53-36)

Similar Bills

No similar bills found.